Tuberculosis prevention and control: the particulate respirator controversy

Today'S OR Nurse
|September 1, 1994
PubMed

Insights

Rising tuberculosis cases, including multidrug-resistant strains, highlight the need for better respiratory protection. Particulate respirators offer enhanced protection over surgical masks but face challenges with cost and patient acceptance.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Occupational Safety

Background:

  • Tuberculosis (TB) incidence has risen since 1984/1985, with over 50,000 excess cases projected between 1985-1992.
  • Many outbreaks are linked to multidrug-resistant Mycobacterium tuberculosis strains.
  • Standard surgical masks may offer insufficient protection against airborne TB transmission.

Purpose of the Study:

  • To evaluate the effectiveness of particulate respirators (PRs) in preventing tuberculosis transmission.
  • To compare the protective capabilities of PRs versus standard surgical masks.
  • To identify challenges associated with the use of recommended respiratory protective equipment.

Main Methods:

  • Review of epidemiological data on tuberculosis case increases.
  • Analysis of the filtration capabilities and facial fit of particulate respirators.
  • Comparison of PRs with standard surgical masks in terms of protection.

Main Results:

  • Particulate respirators offer superior filtration and a tighter facial seal compared to surgical masks.
  • High-efficiency particulate air (HEPA) respirators are certified for 1-micron particle filtration.
  • HEPA respirators are costly and can be perceived as intimidating by patients.

Conclusions:

  • Particulate respirators represent a potentially more effective protective measure against tuberculosis than surgical masks.
  • Barriers to PR adoption, including cost and patient acceptance, need to be addressed.
  • Further research into accessible and user-friendly respiratory protection for TB control is warranted.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...